GELS
Price:
$1.1
Market Cap:
$15.21M
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2024-10-29
Stock Exchange
NASDAQ
Ticker
GELS
According to Gelteq Limited Ordinary Shares’s latest financial reports and current stock price. The company's current ROE is -21.00%. This represents a change of 392.54% compared to the average of -4.26% of the last 4 quarters.
The mean historical ROE of Gelteq Limited Ordinary Shares over the last ten years is -45.90%. The current -21.00% ROE has changed -54.25% with respect to the historical average. Over the past ten years (40 quarters), GELS's ROE was at its highest in in the March 2022 quarter at 0%. The ROE was at its lowest in in the June 2024 quarter at -7.50%.
Average
-45.90%
Median
-18.79%
Minimum
-168.37%
Maximum
-2.72%
Discovering the peaks and valleys of Gelteq Limited Ordinary Shares ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 492.84%
Maximum Annual ROE = -2.72%
Minimum Annual Increase = -98.38%
Minimum Annual ROE = -168.37%
| Year | ROE | Change |
|---|---|---|
| 2024 | -23.47% | 24.87% |
| 2023 | -18.79% | 16.33% |
| 2022 | -16.15% | 492.84% |
| 2021 | -2.72% | -98.38% |
The current ROE of Gelteq Limited Ordinary Shares (GELS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-19.47%
5-year avg
-45.90%
10-year avg
-45.90%
Gelteq Limited Ordinary Shares’s ROE is greater than Biofrontera Inc. (-1151.42%), greater than Immuron Limited (-56.67%), greater than Cocrystal Pharma, Inc. (-129.69%), greater than Sunshine Biopharma, Inc. (-26.25%), greater than ProPhase Labs, Inc. (-409.18%), greater than Aytu BioPharma, Inc. (-47.40%), greater than Imunon, Inc. (-336.51%), less than Evogene Ltd. (438.89%), greater than Bullfrog AI Holdings, Inc. Common Stock (-218.20%), greater than BioNexus Gene Lab Corp. (-30.19%),
| Company | ROE | Market cap |
|---|---|---|
| -1151.42% | $9.65M | |
| -56.67% | $8.88M | |
| -129.69% | $10.61M | |
| -26.25% | $7.06M | |
| -409.18% | $6.30M | |
| -47.40% | $15.96M | |
| -336.51% | $10.08M | |
| 438.89% | $9.59M | |
| -218.20% | $11.18M | |
| -30.19% | $7.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gelteq Limited Ordinary Shares using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gelteq Limited Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Gelteq Limited Ordinary Shares's ROE?
How is the ROE calculated for Gelteq Limited Ordinary Shares (GELS)?
What is the highest ROE for Gelteq Limited Ordinary Shares (GELS)?
What is the 3-year average ROE for Gelteq Limited Ordinary Shares (GELS)?
What is the 5-year average ROE for Gelteq Limited Ordinary Shares (GELS)?
How does the current ROE for Gelteq Limited Ordinary Shares (GELS) compare to its historical average?